stockportfolio.pro
Stocks / IQV vs ONC
IQV vs ONC
IQVIA Holdings Inc. and BeOne Medicines AG side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
IQV is the larger company ($28.5B vs $27.0B). On the fundamentals, ONC grows revenue faster (76.8% vs 7.5%); IQV earns a higher net margin (8.3% vs 5.4%); IQV has the stronger return on equity (20.9% vs 6.6%). Full numbers below — the stronger figure on each row is in green.
| IQVIA Holdings Inc. (IQV) | BeOne Medicines AG (ONC) | |
|---|---|---|
| Market cap | $28.5B | $27.0B |
| Revenue (latest FY) | $16.31B | $5.34B |
| Net income (latest FY) | $1.36B | $286.93M |
| Revenue growth (5y CAGR) | 7.5% | 76.8% |
| Net margin | 8.3% | 5.4% |
| Return on equity | 20.9% | 6.6% |
| P/E ratio | 21.2 | 58.8 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 1 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full IQV vs ONC breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open IQV's full financials → Open ONC's full financials →More comparisons
Frequently asked questions
Which is bigger, IQV or ONC?
IQVIA Holdings Inc. is larger by market capitalization — $28.5B versus $27.0B.
Which grows faster, IQV or ONC?
Over the last five fiscal years, BeOne Medicines AG grew revenue faster — 76.8%/yr versus 7.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.